Phase 1 Not Yet Recruiting

GBP-213

Sponsor

RenJi Hospital, Shanghai Jiao Tong University

Trial Name

Early Phase 1 Dose Escalation/Expansion

Start Date

2026-11

Est. Completion

2027-07

Participants

24

Location

Shanghai, China

NCT ID

NCT07891364

Mechanism

Undisclosed. Given as a subcutaneous injection; the registry does not name the target.

Detailed article coming soon. See the trial details above for current information.

Disclaimer: This information is for educational purposes only and is not medical advice. Clinical trial information is based on publicly available data from ClinicalTrials.gov and published research. Consult your nephrologist before making treatment decisions.

Stay Updated on PKD Research

Get notified when new drugs enter clinical trials, trial results are published, or approved treatments change.

No spam. Unsubscribe anytime.